Development of Rho-kinase inhibitors for cardiovascular medicine

H Shimokawa, M Rashid - Trends in pharmacological sciences, 2007 - cell.com
Rho-kinase (ROCK) is one of the downstream effectors of the small G-protein Rho. The Rho–
ROCK pathway has an important role in mediating various cellular functions, including …

Rho kinase as a therapeutic target in cardiovascular disease

M Surma, L Wei, J Shi - Future cardiology, 2011 - Future Medicine
Rho kinase (ROCK) belongs to the AGC (PKA/PKG/PKC) family of serine/threonine kinases
and is a major downstream effector of the small GTPase RhoA. ROCK plays central roles in …

Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases

M Dong, BP Yan, JK Liao, YY Lam, GWK Yip… - Drug discovery today, 2010 - Elsevier
The Rho/rho-kinase (ROCK) pathway has an important role in the pathogenesis of several
cardiovascular diseases. The activation of ROCK is involved in the regulation of vascular …

2015 ATVB Plenary Lecture: Translational Research on Rho-Kinase in Cardiovascular Medicine

H Shimokawa, K Satoh - Arteriosclerosis, thrombosis, and vascular …, 2015 - Am Heart Assoc
Rho-kinase (ROCKs) is an important downstream effector of the small GTP-binding protein
Ras homolog gene family member A. There are 2 isoforms of ROCK, ROCK1 and ROCK2 …

Rho kinase (ROCK) inhibitors

JK Liao, M Seto, K Noma - Journal of cardiovascular …, 2007 - journals.lww.com
The Rho kinase (ROCK) isoforms, ROCK1 and ROCK2, were initially discovered as
downstream targets of the small GTP-binding protein Rho. Because ROCKs mediate various …

Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity

C Hahmann, T Schroeter - Cellular and Molecular Life Sciences, 2010 - Springer
The emerging critical implications of Rho/Rho-kinase (ROCK) signaling in
neurodegenerative diseases, glaucoma, renoprotection, diabetes and cancer have sparked …

[HTML][HTML] The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease

S Hartmann, AJ Ridley, S Lutz - Frontiers in pharmacology, 2015 - frontiersin.org
Rho-associated kinases ROCK1 and ROCK2 are serine/threonine kinases that are
downstream targets of the small GTPases RhoA, RhoB, and RhoC. ROCKs are involved in …

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges

E Hu, D Lee - Expert Opinion on Therapeutic Targets, 2005 - Taylor & Francis
Rho kinase (ROCK) belongs to a family of Ser/Thr protein kinases that are activated via
interaction with the small GTP-binding protein RhoA. Growing evidence suggests that RhoA …

ROCKs as therapeutic targets in cardiovascular diseases

Y Rikitake, JK Liao - Expert review of cardiovascular therapy, 2005 - Taylor & Francis
There is growing evidence that Rho-kinases (ROCKs), the immediate downstream targets of
the small guanosine triphosphate-binding protein Rho, may contribute to cardiovascular …

Physiological role of ROCKs in the cardiovascular system

K Noma, N Oyama, JK Liao - American Journal of …, 2006 - journals.physiology.org
Rho-associated kinases (ROCKs), the immediate downstream targets of RhoA, are
ubiquitously expressed serine-threonine protein kinases that are involved in diverse cellular …